Column Group Opportunity III, LP

10% Owner · Eikon Therapeutics, Inc.

Every open-market stock purchase Column Group Opportunity III, LP has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought
$50.1M
Open-market buys
6
Companies
2
Last buy
Feb 6, 2026

Where the buys stand today

  • EIKN
    Eikon Therapeutics, Inc.
    −31.9% vs price paid

    3 purchases totalling $38.1M at an average of $18.00 per share; the stock last traded at $12.25. See all insider buying in EIKN

    Avg price paid
    $18.00
    Latest price
    $12.25
    Market cap
    $663.2M
  • SRZN
    Surrozen, Inc./DE

    3 purchases totalling $12.0M at an average of $11.60 per share. See all insider buying in SRZN

    Avg price paid
    $11.60
    Latest price
    Market cap
    $296.3M

Cluster participation

Buys that landed within days of other insiders buying the same stock — the pattern this site exists to catch.

All reported buys

DateTickerSharesPriceValueFiling
Feb 6, 2026
EIKNcluster
630,881$18.00$11.4MSEC ↗
Feb 6, 2026
EIKNcluster
49,556$18.00$892.0KSEC ↗
Feb 6, 2026
EIKNcluster
1,437,323$18.00$25.9MSEC ↗
Mar 26, 2025344,827$11.60$4.0MSEC ↗
Mar 26, 2025365,769$11.60$4.2MSEC ↗
Mar 26, 2025323,886$11.60$3.8MSEC ↗

Get alerted the next time Column Group Opportunity III, LP — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

About this data

Figures are parsed from Column Group Opportunity III, LP's Form 4 filings on SEC EDGAR (CIK 1931825) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.